Article
2016 is coming to a close, so we thought we'd take a look back at some of our top-read contributor columns of the year.
FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis in Adults and Children
FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis in Adults and Children
2 Commerce Drive
Cranbury, NJ 08512